KYBELLAโข FREQUENTLY ASKED QUESTIONS
WHAT IS SUBMENTAL FULLNESS?

- Submental fullness, sometimes referred to as โdouble chin,โ is a common, yet under-treated facial aesthetic condition. It can detract from an otherwise balanced and harmonious facial appearance โ leading to an older and heavier look.
- Submental fullness can impact a broad range of adults, including both women and men, and can be caused by aging, genetics and weight gain.
WHAT IS KYBELLAโข (DEOXYCHOLIC ACID) INJECTION?
- KYBELLAโข (deoxycholic acid) injection, also known as ATX-101, is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness due to submental fat.
- KYBELLAโข is indicated for improvement in the appearance of moderate to severe fullness associated with submental fat in adults.
HOW DOES KYBELLAโข WORK?

- KYBELLAโข is a non-human and non-animal formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
- When injected into subcutaneous fat, KYBELLAโข causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment with KYBELLAโข is not expected.
- The fat pocket under the chin is treated with injections to the area using a very fine needle. The procedure takes approximately 15-20 minutes, and a second treatment approximately one to two months afterward is typically recommended for maximum results.
WHAT ARE THE RESULTS OF KYBELLAโข?

- 68.2% of subjects treated with KYBELLAโข were responders compared to 20.5% of placebo-treated subjects, based upon validated physician and patient measurements.*
- KYBELLAโข treatment resulted in high patient satisfaction โ 79% of KYBELLAโข-treated patients reported satisfaction with their appearance in association with their face and chin.
- Patients also reported improvement in the visual and emotional impact of submental fat when asked how happy, bothered, self-conscious, embarrassed, old and overweight they felt following treatment in relation to the amount of their submental fat.
WHAT ARE THE SIDE EFFECTS WITH KYBELLAโข?

- The safety profile of KYBELLAโข is well-characterized.
- KYBELLAโข has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with KYBELLAโข.
- KYBELLAโข is manufactured through a highly-controlled, FDA-regulated process and approved facility to ensure patient safety.
- The most common adverse reactions were edema/swelling, hematoma/bruising, pain, numbness, erythema and induration.
- Marginal mandibular nerve (MMN) injury occurred in 4% and dysphagia occurred in 2% of subjects. To avoid potential tissue damage, KYBELLAโข should not be injected into or in close proximity (1-1.5 cm) to the MMN, salivary glands, lymph nodes and muscles.
[link pid=86]INTERESTED? CONTACT US FOR A COMPLIMENTARY CONSULTATION.[/link]